The illustrated photo shows a vial and syringe with the Covid-19 vaccine sticker bearing the logo of the US pharmaceutical company Johnson & Johnson on November 17, 2020. (Photo courtesy of JUSTIN TALLIS / AFP) (Photo courtesy of JUSTIN TALLIS / AFP, Getty Images)
(((NewsNation Now) — US health officials said on Friday that a booster dose of Johnson & Johnson’s COVID-19 vaccine should be approved and delivered at least two months after immunization.
J & J is asking the Food and Drug Administration for booster flexibility, claiming that additional doses will add significant protection two months after the first vaccination, but waiting up to six months will work. There is a possibility.
The FDA’s advisory board unanimously voted that boosters should be provided without a firm time. Advisors say that those who have been vaccinated with J & J appear to be less protected than those who have received the Pfizer or Moderna double vaccination option, and most people receive that single dose months ago. He said there was growing concern that he had received it.
The FDA is not bound by voting, but its final decision may help expand the country’s booster campaign.
This is just the first step in the review process, including approval from both the FDA and the US Centers for Disease Control and Prevention leaders. If both institutions move forward, Americans may start getting J & J boosters later this month.
But earlier this week, FDA scientists said they didn’t receive enough data to do their own analysis of Booster’s J & J application, but a review of the FDA’s corporate survey found some dangers. A signal has occurred.
In that review, FDA scientists repeatedly mentioned the limitations of small sample sizes in many of the company’s studies.
The data they used to support booster dosing 6 months after the first shot have not been validated and probably rely on tests to measure immune responses that are not sufficiently sensitive. Said.
That discrepancy in the assessment tools will make it difficult to make meaningful comparisons with data from the company’s larger double-dose booster trials.
Thursday’s FDA Half-dose booster for Moderna’s COVID-19 vaccine As a booster for the elderly and other high-risk groups.
The FDA’s meeting is held because US vaccinations averaged over 1 million per day and increased by more than 50% in the last two weeks.The rise is mainly with Pfizer boosters Employer’s vaccination obligation.
According to data edited by, 56.6% of all Americans are fully vaccinated and 4.7% of the total population is boosted. CDC..
FDA Approves Johnson & Johnson COVID Booster | WGN Radio 720
Source link FDA Approves Johnson & Johnson COVID Booster | WGN Radio 720
The post FDA Approves Johnson & Johnson COVID Booster | WGN Radio 720 appeared first on Illinois News Today.
No comments:
Post a Comment